Danone plans to double India sales in 3 years
MUMBAI (Reuters) - French food group Danone (DANO.PA) plans to double its sales in India in the next three years, a company executive said, as the world's top yogurt maker raises focus on emerging markets to drive growth when its traditional European markets are slowing.
Danone early this year paid about $355 million to buy Indian drugmaker Wockhardt's (WCKH.NS) nutrition business that sells popular brands such as Dexolac, Farex and Nusobee. The brands compete with Danone's top global rival Nestle (NESN.VX).
"India's growth in nutrition sector will outpace China's (growth)," Laurent Marcel, managing director at Danone's India nutrition business unit, told reporters on Thursday. "We are here to expand, grow the business."
India's baby nutrition market is valued about 25 billion rupees, in which Danone holds about 8 percent share, he said. (Reporting by Kaustubh Kulkarni; Editing by Sunil Nair)
- Tweet this
- Share this
- Digg this
- Alibaba surges on massive demand in trading debut
- Eight bodies found after attack on Guinea Ebola education team
- EU relief at Scotland's "no" tinged with fear of nationalism
- UPDATE 8-Scots spurn independence in historic vote, nationalist leader resigns
- Kurdish leader urges world to protect Syrian town from Islamic State
India has capped the prices of 36 drugs, including those used to treat infections and diabetes, in its latest move to make essential medicines more affordable, a senior official of the country's drug pricing authority told Reuters on Friday. Full Article
Top rice exporter India importing over 100,000 T on temporary supply squeeze. Full Article